-
1
Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model
Published 2020-06-01Subjects: Get full text
Article -
2
Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
Published 2021-03-01Subjects: Get full text
Article -
3
Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis
Published 2018-08-01Subjects: Get full text
Article -
4
Optimal radiation dose to induce an abscopal effect by combining carbon-ion radiotherapy and anti-CTLA4 antibody
Published 2025-02-01Subjects: Get full text
Article -
5
Inhibition of CTLA-4 accelerates atherosclerosis in hyperlipidemic mice by modulating the Th1/Th2 balance via the NF-κB signaling pathway
Published 2024-09-01Subjects: “…Anti-CTLA-4 antibody…”
Get full text
Article -
6
Antitumor effect of plant-produced anti-CTLA-4 monoclonal antibody in a murine model of colon cancer
Published 2023-08-01Subjects: Get full text
Article -
7
-
8
Severe autoimmune hemolytic anemia following immunotherapy with checkpoint inhibitors in two patients with metastatic melanoma: a case report
Published 2024-03-01Subjects: Get full text
Article -
9
Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors
Published 2022-09-01Subjects: Get full text
Article